{"title":"抗核抗体(ANA)在脊椎关节病中的患病率及临床相关性。","authors":"Adrianna Błahuszewska-Omyła , Emilia Frąckiel , Marek Bielecki , Ewa Gińdzieńska- Sieśkiewicz , Natalia Szymańska , Otylia Kowal-Bielecka","doi":"10.1016/j.advms.2025.09.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Spondyloarthropathies (SpA) are a broad and diverse group of diseases with highly variable clinical manifestations. Due to this wide range of symptoms and their frequent overlap with other disease entities, SpA present numerous diagnostic and therapeutic challenges. Moreover, the pathogenesis of SpA remains unexplained. While the currently prevailing hypothesis suggests an autoinflammatory mechanism, the involvement of autoimmune processes has not been ruled out. To explore this possibility, the present study aimed to assess the presence of antinuclear antibodies (ANA) and their clinical associations in patients with SpA.</div></div><div><h3>Patients and methods</h3><div>The analysis included 117 consecutive patients with different forms of SpA, i.e., ankylosing spondylitis (n = 52), psoriatic arthritis (n = 34), and non-radiographic SpA (n = 31). They underwent clinical evaluation, and serum samples were collected from each for ANA testing using indirect immunofluorescence.</div></div><div><h3>Results</h3><div>ANA were found in 46 % of patients with SpA. No statistically significant association was found between ANA and diagnosis of specific SpA or clinical symptoms. Interestingly, the highest prevalence of ANA (63 %) was found in women with non-radiographic spondyloarthropathy and the lowest (38 %) in males with ankylosing spondylitis, however, the difference did not reach statistical significance.</div></div><div><h3>Conclusion</h3><div>The results of our study suggest that ANA are frequent in patients with SpA, in particular in women with early, non-radiographic SpA which may be of clinical significance. However, further studies, involving larger populations, are necessary to clarify the significance of ANA presence in SpA patients.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 2","pages":"Pages 377-381"},"PeriodicalIF":2.6000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence and clinical associations of antinuclear antibodies (ANA) in spondyloarthropathies\",\"authors\":\"Adrianna Błahuszewska-Omyła , Emilia Frąckiel , Marek Bielecki , Ewa Gińdzieńska- Sieśkiewicz , Natalia Szymańska , Otylia Kowal-Bielecka\",\"doi\":\"10.1016/j.advms.2025.09.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><div>Spondyloarthropathies (SpA) are a broad and diverse group of diseases with highly variable clinical manifestations. Due to this wide range of symptoms and their frequent overlap with other disease entities, SpA present numerous diagnostic and therapeutic challenges. Moreover, the pathogenesis of SpA remains unexplained. While the currently prevailing hypothesis suggests an autoinflammatory mechanism, the involvement of autoimmune processes has not been ruled out. To explore this possibility, the present study aimed to assess the presence of antinuclear antibodies (ANA) and their clinical associations in patients with SpA.</div></div><div><h3>Patients and methods</h3><div>The analysis included 117 consecutive patients with different forms of SpA, i.e., ankylosing spondylitis (n = 52), psoriatic arthritis (n = 34), and non-radiographic SpA (n = 31). They underwent clinical evaluation, and serum samples were collected from each for ANA testing using indirect immunofluorescence.</div></div><div><h3>Results</h3><div>ANA were found in 46 % of patients with SpA. No statistically significant association was found between ANA and diagnosis of specific SpA or clinical symptoms. Interestingly, the highest prevalence of ANA (63 %) was found in women with non-radiographic spondyloarthropathy and the lowest (38 %) in males with ankylosing spondylitis, however, the difference did not reach statistical significance.</div></div><div><h3>Conclusion</h3><div>The results of our study suggest that ANA are frequent in patients with SpA, in particular in women with early, non-radiographic SpA which may be of clinical significance. However, further studies, involving larger populations, are necessary to clarify the significance of ANA presence in SpA patients.</div></div>\",\"PeriodicalId\":7347,\"journal\":{\"name\":\"Advances in medical sciences\",\"volume\":\"70 2\",\"pages\":\"Pages 377-381\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in medical sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1896112625000409\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in medical sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1896112625000409","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Prevalence and clinical associations of antinuclear antibodies (ANA) in spondyloarthropathies
Purpose
Spondyloarthropathies (SpA) are a broad and diverse group of diseases with highly variable clinical manifestations. Due to this wide range of symptoms and their frequent overlap with other disease entities, SpA present numerous diagnostic and therapeutic challenges. Moreover, the pathogenesis of SpA remains unexplained. While the currently prevailing hypothesis suggests an autoinflammatory mechanism, the involvement of autoimmune processes has not been ruled out. To explore this possibility, the present study aimed to assess the presence of antinuclear antibodies (ANA) and their clinical associations in patients with SpA.
Patients and methods
The analysis included 117 consecutive patients with different forms of SpA, i.e., ankylosing spondylitis (n = 52), psoriatic arthritis (n = 34), and non-radiographic SpA (n = 31). They underwent clinical evaluation, and serum samples were collected from each for ANA testing using indirect immunofluorescence.
Results
ANA were found in 46 % of patients with SpA. No statistically significant association was found between ANA and diagnosis of specific SpA or clinical symptoms. Interestingly, the highest prevalence of ANA (63 %) was found in women with non-radiographic spondyloarthropathy and the lowest (38 %) in males with ankylosing spondylitis, however, the difference did not reach statistical significance.
Conclusion
The results of our study suggest that ANA are frequent in patients with SpA, in particular in women with early, non-radiographic SpA which may be of clinical significance. However, further studies, involving larger populations, are necessary to clarify the significance of ANA presence in SpA patients.
期刊介绍:
Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines.
The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments.
Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines.
The journal welcomes submissions from the following disciplines:
General and internal medicine,
Cancer research,
Genetics,
Endocrinology,
Gastroenterology,
Cardiology and Cardiovascular Medicine,
Immunology and Allergy,
Pathology and Forensic Medicine,
Cell and molecular Biology,
Haematology,
Biochemistry,
Clinical and Experimental Pathology.